Home › Steatotic Liver Disease › Texas › Corpus Christi
Steatotic Liver Disease clinical trials in Corpus Christi, TX
3 studies for Steatotic Liver Disease are looking for participants at sites in and around Corpus Christi (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Corpus Christi
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RecruitingPhase 3
- Akero Clinical Study Site, Corpus Christi
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RecruitingPhase 2
- Pinnacle Clinical Research, Corpus Christi
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- Miami, FL16 studies
- New York City, NY16 studies
- San Diego, CA14 studies
- Austin, TX13 studies
- Houston, TX13 studies
- Richmond, VA12 studies
- Tucson, AZ10 studies
- Chandler, AZ10 studies
- Orlando, FL9 studies
- St. Louis, MO9 studies
- Dallas, TX9 studies
Other studies in Corpus Christi
- Obesity6 studies
- Overweight5 studies
- Burkitt Lymphoma4 studies
- Type 2 Diabetes4 studies
- Acute Biphenotypic Leukemia3 studies
- Acute Myeloid Leukemia3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.